Human beings are composed of trillions of cells. Cells are the basic units of life. It is the key to understanding health and disease biology. Before we have a certain understanding of cells according to the surface markers, location, shape and function of cells, we have limited understanding of the cell types and status of every organ and the difference between cells in every organ. I don't even know how many different types of cells in the body. Human cell mapping is getting cells of the new era, the single cell profiles of different tissues draw the human physiological and pathological conditions, will help identify cells in development and disease during the period of how to change with time, the discovery of new cell types, which is expected for early diagnosis of disease and provide personalized molecular precise treatment the diagnosis and treatment of targets and provide treatment for some diseases.

In the US Pacific time October 16, 2017, the first 38 projects to be funded by the "human cell map program", which are comparable to the "human genome project", were officially announced. Zhang Xuegong Laboratory of Tsinghua University has successfully obtained part of the project funds by virtue of abundant single cell transcriptome bioinformatics analysis experience, and became the only Chinese scientist team to undertake the project.

The human cell Atlas (Human Cell AtlasProject) is a large-scale international cooperation project, launched in 2016 by the Massachusetts Institute of Technology and Harvard University and other units, according to the unique molecular information (such as gene expression) definition for all cell types of human, and the expression of these information and the traditional cytology (such as location and morphology) associated; committed to the establishment of a healthy human body contains all of the cells of the reference map, including cell type, number, location, interaction and molecular composition. The plan is based on the discussion of excellent biologists, technologists, pathologists, physicians, surgeons, computer scientists and statisticians all over the world, and puts forward an epoch-making international cooperation project.

In September 2017, China established the research alliance of human blood cell molecular map (ABC), and comprehensively analyzed and plotted blood cell molecular map and heterogeneity rule of single cell level normal subjects and patients with various hematopathy. In addition, the molecular cell map of other organs is also carried out in full swing.

人は數(shù)兆細(xì)胞から構(gòu)成して、細(xì)胞は生命の基本単位は、理解の健康と疾病生物學(xué)の鍵。前に私たちによって細(xì)胞の表面のシンボル、位置、形や機(jī)能などは細(xì)胞が一定の認(rèn)識(shí)が、私たちは各器官のあらゆる細(xì)胞の種類や狀態(tài)など、細(xì)胞の各器官の違いを理解してとても有限。體內(nèi)にどのような種類の細(xì)胞があるかは知らない。人間の細(xì)胞マップは理解を構(gòu)築する細(xì)胞の新時(shí)代を描き、人體の生理と病理狀態(tài)で異なる組織の単細(xì)胞の図鑑、役立つ発見細(xì)胞の発育や疾患の発生期間どのように時(shí)間をかけて変更し、新しい細(xì)胞のタイプを発見して、それによって期待を疾患の早期診斷と治療提供な個(gè)性の分子診療標(biāo)的といくつかの疑難疾患治療プランを提供する。

アメリカ太平洋時(shí)間2017年10月16日、「人類のゲノム計(jì)畫」に匹敵する「人類細(xì)胞マップ計(jì)畫」の第1弾支援の38項(xiàng)目が正式に発表された。清華大學(xué)張學(xué)工実験室で豊かな単細(xì)胞生物情報(bào)分析転寫組に成功経験部分プロジェクト基金は、*の負(fù)擔(dān)になるプロジェクトの中國(guó)の科學(xué)者チーム。

人間の細(xì)胞の図鑑計(jì)畫（ヒューマン?Cell AtlasProject）は1つの大型國(guó)際協(xié)力プロジェクトは、マサチューセッツ工科大學(xué)とハーバード大學(xué)など複數(shù)の単位は2016年に開始、*の分子情報(bào)（例えば遺伝子発現(xiàn)）すべての人間の細(xì)胞の種類を定義し、これらの情報(bào)と伝統(tǒng)の細(xì)胞學(xué)表現(xiàn)（例えば位置と形態(tài)）相関係の確立を目指しており健康人體に含まれるすべての細(xì)胞と細(xì)胞のタイプを參考にマップを含む、數(shù)目、位置、相互関連と分子組等級(jí)を分ける。この計(jì)畫は*範(fàn)囲內(nèi)でを通じて優(yōu)秀な生物學(xué)者、技術(shù)専門家、病理學(xué)者、內(nèi)科、外科醫(yī)、コンピュータ科學(xué)者、統(tǒng)計(jì)學(xué)者などを共同で検討し、提出して、畫期的な國(guó)際協(xié)力プロジェクト。

2017年9月、中國(guó)は人の血細(xì)胞分子マップ（ABC）の研究連盟を設(shè)立し、単細(xì)胞レベルの正常な人間および各種の血液病患者の血細(xì)胞分子マップとその異質(zhì)性の法則を全面的に解析した。また、他の器官の分子細(xì)胞マップの研究も盛んに展開されている。

上一篇：IGH（14q32）基因斷裂探針

下一篇：MYEOV/IGH融合基因t（11;14）探針

返回列表>>

廣州健侖生物科技有限公司(www.backhome.top) 熱門產(chǎn)品:喹諾酮類檢測(cè)試劑盒,西尼羅河檢測(cè)試劑,基孔肯雅熱試劑,寨卡檢測(cè)試劑,疫病核酸試劑
地址：廣東省廣州市番禺區(qū)石樓鎮(zhèn)清華科技園創(chuàng)啟路63號(hào)A2棟101 Email：service@jianlun.com
ICP備：粵ICP備11063766號(hào) GoogleSitemap 技術(shù)支持：化工儀器網(wǎng) 管理登陸返回首頁(yè)